project id: TCGA-OV; case submitter id: TCGA-30-1861; selected normal wgs: true; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 9.3; spectrophotometer method: UV Spec; age at index: 74; days to birth: -27103; days to death: 1058; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1928; year of death: 2004; age at diagnosis: 27103; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1058.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2002; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 0.4; longest dimension: 0.8; preservation method: Unknown; shortest dimension: 0.4; sample id: 2642249c-adc7-48e2-8493-1597e269c2c9; sample submitter id: TCGA-30-1861-01A; portion id: 6ee2c939-e84c-4211-878d-e899a27faf00; portion submitter id: TCGA-30-1861-01A-01; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 80.0;